Skip to main content

Superantigens in demyelinating disease

  • Chapter
Immunoneurology

Abstract

Autoreactive T cells are part of the normal lymphocyte repertoire of healthy individuals [4]. In the immune system of healthy individuals, potent regulatory mechanisms control T and B cell tolerance to self antigens. While genetic factors influence susceptibility to autoimmunity in humans and experimental animals, environmental factors contribute to disease penetration. For autoimmune disease to occur, autoreactive lymphocytes have to be activated in vivo or in vitro. This process leads to the clonal expansion of autoreactive cells. In addition, during the initiation phase of demyelinating disease, only activated autoreactive lymphocytes migrate through the endothelial cell layer of the intact blood-brain barrier (BBB).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bergdoll MS (1995) Importance of staphylococci that produce nanogram quantities of enterotoxin. Int J Med Microbiol 282: 1

    CAS  Google Scholar 

  2. Brocke S, et al (1993) Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365: 642

    Article  PubMed  CAS  Google Scholar 

  3. Brocke S, et al (1994) Infection and multiple sclerosis: a possible role for superantigens? Trends Microbiol 2: 250

    Article  PubMed  CAS  Google Scholar 

  4. Burns J, Rosenzweig A, Zweiman B, Lisak RP (1983) Isolation of myelin basic protein-reactive T cell lines from normal human blood. Cell Immunol 81: 435

    Article  PubMed  CAS  Google Scholar 

  5. Gaur A, et al (1993), SEB induced anergy: modulation of immune response to T cell determinants of myoglobin and myelin basic protein. J Immunol 150: 3062

    PubMed  CAS  Google Scholar 

  6. Hudson KR, et al (1995) Staphylococcal enterotoxin has two cooperative binding sites on major histocompatibility complex class II. J Exp Med 182: 711

    Article  PubMed  CAS  Google Scholar 

  7. Hurley JM, et al (1995) Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J. Exp Med 181: 2229

    Article  PubMed  CAS  Google Scholar 

  8. Jardetzky TS, et al (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368: 711

    Article  PubMed  CAS  Google Scholar 

  9. Kalman B, et al (1993) Effects of staphylococcal enterotoxin B on T cell receptor V beta utilization and clinical manifestations of experimental allergic encephalomyelitis. J Neuroimmunol 45: 83

    Article  PubMed  CAS  Google Scholar 

  10. Kappler JW, et al (1992) Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med 175: 387

    Article  PubMed  CAS  Google Scholar 

  11. Kim C, Siminovitch KA, Ochi A (1991) Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment. J Exp Med 174: 1431

    Article  PubMed  CAS  Google Scholar 

  12. Kim J, et al (1994) Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266: 1870

    Article  PubMed  CAS  Google Scholar 

  13. Kotzin BL (1994) Superantigens and their role in disease. Hosp Prac (Off Ed) 29: 59

    CAS  Google Scholar 

  14. Kotzin BL, et al (1993) Superantigens and their potential role in human disease. Adv Immunol 54: 99

    Article  PubMed  CAS  Google Scholar 

  15. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248: 705

    Article  PubMed  CAS  Google Scholar 

  16. Rott O, Wekerle H, Fleischer B (1992) Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen. Int Immunol 4: 347

    Article  PubMed  CAS  Google Scholar 

  17. Schiffenbauer J, et al (1993) Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci 90: 8543

    Article  PubMed  CAS  Google Scholar 

  18. Seth A, et al (1994) Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 369: 324

    Article  PubMed  CAS  Google Scholar 

  19. Soos JM, Schiffenbauer J, Johnson HM (1993) Treatment of PL/J mice with the superantigen staphylococcal enterotoxin B prevents development of experimental allergic encephalomyelitis. J Neuroimmunol 43: 39

    Article  PubMed  CAS  Google Scholar 

  20. Soos JM, et al (1995) Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen. Proc Natl Acad Sci USA 92: 6082

    Article  PubMed  CAS  Google Scholar 

  21. Steinman L (1994) Specific motifs in T cell receptor V beta D beta J beta gene sequences in multiple sclerosis lesions in brain. Behring Inst Mitt 94: 148

    PubMed  CAS  Google Scholar 

  22. Stinissen P, et al (1995) Increased frequency of γδ T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. J Immunol 154: 4883

    PubMed  CAS  Google Scholar 

  23. Swaminathan S, et al (1992) Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359: 801

    Article  PubMed  CAS  Google Scholar 

  24. Ulrich RG, Bavari S, Olson MA, (1995) Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules. Nature Struct Biol 2: 554

    Article  PubMed  CAS  Google Scholar 

  25. Vinken PJ, et al (eds) (1989) Handb Clin Neurol vol 56, Elsevier Science Publishers

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Brocke, S., Piercy, C., Steinman, L. (1996). Superantigens in demyelinating disease. In: Chofflon, M., Steinman, L. (eds) Immunoneurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61191-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-61191-9_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64741-3

  • Online ISBN: 978-3-642-61191-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics